PROM1 and glioblastoma: Fan et al. (2009) described a block in the Notch pathway using a specific agent, GSI-18, that depletes CD133+ glioblastoma cells and inhibits growth of tumor spheres in xenografts, with decreased Akt and Stat3 phosphorylation status.